Proposed change of company english name
Filed with HKEX · Stock code 1312 · · 3 pages · English
Summary by 6ix AI
Kontafarma China Holdings Ltd has proposed to change its English name to Kontafarma Holdings Limited, while retaining its Chinese name. This change is subject to shareholder approval at an extraordinary general meeting and the Registrar of Companies in the Cayman Islands. The board believes the new name better reflects the company's focus on its pharmaceutical business and avoids geographical limitations. The proposed name change will not affect shareholders' rights or the company's operations, and existing share certificates will remain valid.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Kontafarma China Holdings Ltd on 6ix
Earlier from Kontafarma China
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31st October, 2026
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30th September, 2026
- MAJOR TRANSACTION (Multi-Files)
- Notification letter to non-registered shareholders and request form - notification of publication of the circular of major transaction in relation to renewal of lease for fitness and yoga centre
- Grant of Waiver for further delay in despatch of circular under rule 14.41(a) of the listing rules
Follow Kontafarma China into a list and get an email when it puts out news.
Follow Kontafarma China